CONFIMIDs - Evaluation of the impact of the lockdown and easing of restrictions on the management of patients with inflammatory disease and immune disorders followed up as part of the FHU IMMINeNT project (rheumatology, dermatology, internal medicine, pulmonology, gastroenterology and neurology)
Head :
DEZOTEUX Frédéric, INSERM U1286 INFINITE
Last update : 05/05/2021 | Version : 1 | ID : 73487
| General | |
| Identification | |
| Detailed name | Evaluation of the impact of the lockdown and easing of restrictions on the management of patients with inflammatory disease and immune disorders followed up as part of the FHU IMMINeNT project (rheumatology, dermatology, internal medicine, pulmonology, gastroenterology and neurology) |
| Sign or acronym | CONFIMIDs |
| CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation | 2020-A01596-33 |
| General Aspects | |
| Medical area |
Dermatology, venereology Gastroenterology et hepatology Immunology Internal medicine Neurology Pneumology Rare diseases Rheumatology |
| Study in connection with Covid-19 |
Yes |
| Health determinants |
Healthcare system and access to health care services Lifestyle and behavior Occupation |
| Scientific investigator(s) (Contact) | |
| Name of the director | DEZOTEUX |
| Surname | Frédéric |
| Address | Rue Michel Polonovski |
| Phone | 320444193 |
| Unit | INSERM U1286 INFINITE |
| Organization | LILLE UNIVERSITY HOSPITAL |
| Collaborations | |
| Participation in projects, networks and consortia |
Yes |
| Funding | |
| Funding status |
Public |
| Governance of the database | |
| Sponsor(s) or organisation(s) responsible | Lille University Hospital |
| Organisation status |
Public |
| Presence of scientific or steering committees |
No |
| Additional contact | |
| Main features | |
| Type of database | |
| Type of database |
Study databases |
| Database recruitment is carried out by an intermediary |
An administrative base or a register |
| Database recruitment is carried out as part of an interventional study |
No |
| Database objective | |
| Main objective | Estimate the frequency of patients, with chronic inflammatory disorders, followed up as part of the FHU IMMINeNT project (gastroenterology, rheumatology, dermatology, pulmonology, neurology, internal medicine), whose follow-up has been affected by the lockdown and easing of restrictions. |
| Inclusion criteria |
All adult patients followed up as part of the FHU project for:
- Chronic inflammatory bowel disease or IBD (Crohn’s disease and ulcerative colitis), - Rheumatic disorders (rheumatoid arthritis and spondyloarthritis) - Multiple sclerosis - Asthma - Psoriasis - Atopic dermatitis - Systemic auto-immune disease (scleroderma and lupus) |
| Population type | |
| Age |
Adulthood (19 to 24 years) Adulthood (25 to 44 years) Adulthood (45 to 64 years) Elderly (65 to 79 years) Great age (80 years and more) |
| Population covered |
Sick population |
| Pathology | G00-G09 - Inflammatory diseases of the central nervous system |
| M34 - Systemic sclerosis | |
| M32 - Systemic lupus erythematosus | |
| L40 - Psoriasis | |
| L20-L30 - Dermatitis and eczema | |
| J45 - Asthma | |
| M05-M14 - Inflammatory polyarthropathies | |
| J84 - Other interstitial pulmonary diseases | |
| K50 - Crohn disease [regional enteritis] | |
| K51 - Ulcerative colitis | |
| L95 - Vasculitis limited to skin, not elsewhere classified | |
| Gender |
Male Woman Other |
| Geography area |
Regional |
| French regions covered by the database |
Nord - Pas-de-Calais Picardie |
| Data collection | |
| Dates | |
| Date of first collection (YYYY or MM/YYYY) | 2020 |
| Date of last collection (YYYY or MM/YYYY) | 2020 |
| Size of the database | |
| Size of the database (number of individuals) |
[1000-10 000[ individuals |
| Details of the number of individuals | 4500 |
| Data | |
| Database activity |
Data collection completed |
| Type of data collected |
Clinical data Declarative data |
| Declarative data (detail) |
Internet self-questionnaire |
| Presence of a biobank |
No |
| Procedures | |
| Participant monitoring |
No |
| Followed pathology | |
| Links to administrative sources |
No |
| Promotion and access | |
| Promotion | |
| Access |
